EUVIMEDEUVIMED entdecken
Crossref

2157-P: Gestational Glucose Intolerance and Incident Maternal Hypertension

CARLA F. ESCOBAR-TOMLIENOVICH, DIANA C. SORIA, DEEPTI PANT, TANAYOTT THAWEETHAI, SARAH HSU, KAITLYN JAMES, JACQUELINE MAYA, CAMILLE POWE

Diabetes · 05.06.2026 · 75 (Supplement_1)

DOI: 10.2337/db26-2157-p ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, erschienen am 05.06.2026. Verfasst von CARLA F. ESCOBAR-TOMLIENOVICH und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction and Objective: Gestational diabetes (GDM) is associated with an increased risk of future hypertension (HTN). We tested if gestational glucose intolerance (GGI), subclinical hyperglycemia in pregnancy, is also associated with an increased HTN risk.

Methods

This was a retrospective study in an electronic health record-based cohort of pregnancies delivered at an academic medical center (1998-2016) that were free of HTN and diabetes at baseline. We defined HTN using problem list terms and ICD codes. We defined GGI as an abnormal glucose loading test followed by an oral glucose tolerance test that did not meet GDM criteria (<2 abnormal values). We categorized deliveries as normal glucose tolerance (NGT), GGI or GDM. We fit a Cox model adjusted for time-invariant (age, race/ethnicity) and time-varying covariates (1st trimester BMI, parity, insurance, marital status, social deprivation index), updated at each delivery. Follow-up began at the first eligible delivery.

Results

We analyzed 37,033 pregnancies in 27,029 individuals with median (IQR) age at delivery and BMI of 31.4 (27.2-34.8) years and 24.0 (21.7-27.3) kg/m2, respectively. During a median follow-up of 12.6 years (IQR 6.1-18.4), there were 1,934 cases (7.2%) of incident HTN. The rate of HTN per 1,000 person-years was 5.9 for NGT, 7.8 for GGI, and 11.3 for GDM. The unadjusted (figure 1) and adjusted HTN risks were higher for GGI (HR 1.17 [95% CI 1.03-1.32]) and GDM (1.35 [1.13-1.63]) compared to NGT.

Conclusion

GGI is associated with future HTN. Disclosure C.F. Escobar-Tomlienovich: None. D.C. Soria: None. D. Pant: None. T. Thaweethai: None. S. Hsu: None. K. James: None. J. Maya: None. C. Powe: Research Support; Current; Dexcom, Inc. Other - Associate Editor of Diabetes Care, Honoraria for Educational Materials; Current; American Diabetes Association. Other - Royalties for Up To Date chapters; Current; Wolters Kluwer (Up To Date). Other - Speaker; Ended; Medscape. Funding American Heart Association (5SFRNPCKMS1463896), NIH/NIDDK (5K26DK138346)

Zitieren

APA

ESCOBAR-TOMLIENOVICH, C. F., SORIA, D. C., PANT, D., THAWEETHAI, T., HSU, S., JAMES, K., MAYA, J., & POWE, C. (2026). 2157-P: Gestational Glucose Intolerance and Incident Maternal Hypertension. Diabetes, 75(Supplement_1). https://doi.org/10.2337/db26-2157-p

Vancouver

ESCOBAR-TOMLIENOVICH CF, SORIA DC, PANT D, THAWEETHAI T, HSU S, JAMES K, et al. 2157-P: Gestational Glucose Intolerance and Incident Maternal Hypertension. Diabetes. 2026;75(Supplement_1). doi:10.2337/db26-2157-p

BibTeX
@article{ESCOBARTOMLIENOVICH2026,
  author = {ESCOBAR-TOMLIENOVICH, CARLA F. and SORIA, DIANA C. and PANT, DEEPTI and THAWEETHAI, TANAYOTT and HSU, SARAH and JAMES, KAITLYN and MAYA, JACQUELINE and POWE, CAMILLE},
  title = {2157-P: Gestational Glucose Intolerance and Incident Maternal Hypertension},
  journal = {Diabetes},
  year = {2026},
  volume = {75},
  number = {Supplement_1},
  doi = {10.2337/db26-2157-p}
}
Kostenlos starten →